Stewart Ralph A H, Colquhoun David M, Marschner Simone L, Kirby Adrienne C, Simes John, Nestel Paul J, Glozier Nick, O'Neil Adrienne, Oldenburg Brian, White Harvey D, Tonkin Andrew M
Green Lane Cardiovascular Service, Auckland City Hospital, University of Auckland, Auckland, New Zealand.
Cardiology Department, Greenslopes Hospital, Brisbane, Queensland, Australia.
Heart. 2017 Dec;103(23):1860-1866. doi: 10.1136/heartjnl-2016-311097. Epub 2017 Jun 26.
A single assessment of psychological distress, which includes depression and anxiety, has been associated with increased mortality in patients with coronary heart disease, but the prognostic importance of persistence of distress symptoms is less certain.
To determine whether intermittent and/or persistent psychological distress is associated with long-term cardiovascular (CV) and total mortality in patients with stable coronary artery disease.
950 participants in the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) trial completed at least four General Health Questionnaires (GHQ-30) at baseline and after ½, 1, 2 and 4 years. In a landmark analysis from 4 years, Cox proportional hazards models evaluated the risk of CV and total mortality by increasing levels of psychological distress: never distressed, sometimes any severity (GHQ score >5), persistent mild (GHQ score >5 on three or more occasions) and persistent moderate distress (GHQ score >10) on three or more occasions, over a median of 12.1 (IQR 8.6-12.5) years. The models were both unadjusted and adjusted for known baseline risk factors.
Persistent moderate or greater psychological stress was reported on three or more assessments by 35 (3.7%) subjects. These patients had a higher risk of both CV death (adjusted HR 3.94, 95% CI 2.05 to 7.56, p<0.001) and all-cause mortality (adjusted HR 2.85, 95% CI 1.74 to 4.66, p<0.001) compared with patients with no distress. In contrast, patients who reported persistent mild distress (n=73, 7.7%) on three or more visits, and those who met criteria for distress on only one or two assessments (n=255, 26.8%), did not have an increased risk of CV or all-cause mortality during follow-up.
In patients with stable coronary artery disease, persistent psychological distress of at least moderate severity is associated with a substantial increase in CV and all-cause mortality.
对包括抑郁和焦虑在内的心理困扰进行单次评估,已发现与冠心病患者死亡率增加有关,但困扰症状持续存在的预后重要性尚不确定。
确定间歇性和/或持续性心理困扰是否与稳定型冠状动脉疾病患者的长期心血管(CV)和全因死亡率相关。
缺血性疾病普伐他汀长期干预试验(LIPID)中的950名参与者在基线时以及在半年、1年、2年和4年后完成了至少四次一般健康问卷(GHQ-30)。在一项从4年开始的标志性分析中,Cox比例风险模型通过心理困扰程度的增加来评估CV和全因死亡率风险:从未困扰、有时有任何严重程度(GHQ评分>5)、持续性轻度(三次或更多次GHQ评分>5)和持续性中度困扰(三次或更多次GHQ评分>10),随访时间中位数为12.1(四分位间距8.6-12.5)年。模型未调整以及针对已知的基线风险因素进行了调整。
35名(3.7%)受试者在三次或更多次评估中报告了持续性中度或更严重的心理压力。与无困扰的患者相比,这些患者发生CV死亡(调整后HR 3.94, 95% CI 2.05至7.56, p<0.001)和全因死亡率(调整后HR 2.85, 95% CI 1.74至4.66, p<0.001)的风险更高。相比之下,在三次或更多次就诊时报告持续性轻度困扰的患者(n=73, 7.7%),以及仅在一次或两次评估中符合困扰标准的患者(n=255, 26.8%),在随访期间CV或全因死亡率风险并未增加。
在稳定型冠状动脉疾病患者中,至少中度严重程度的持续性心理困扰与CV和全因死亡率大幅增加相关。